ADAMTS9 and breast cancer: Another study on Indian breast cancer showed ADAMTS9-AS2, EPB41L4A-AS1, WDFY3-AS2, RP11-295M3.4, RP11-161M6.2, RP11-490M8.1, CTB-92J24.3, and FAM83H-AS1 to be deregulated in early-stage breast cancer (Deva Magendhra Rao et al., 2019).